English

2021 West Oncology APP | Treatment Options for Elderly AML/MDS Patients

Published 2021-10-04

Download video

Download video MP4 360p

Recommendations

19:15

2021 West Oncology APP | Update on Myeloma
1:00:46

Triple Negative Breast Cancer Case Panel Discussion | 2022 Best of Breast Conference
43:25

Safety Considerations for the Development of Antibody Drug Conjugates
1:18:22

Seizures in Dogs and Cats || SEVN Webinar Series
01:32

Follow the Evidence
51:31

Dr. Deb Schrag discusses the PROSPECT Trial as part of this DocTalk
18:46

Approach to the Exam for Parkinson's Disease
54:15

Technological Competence as Caring in Nursing: An Interview with Theorist Rozzano Locsin
1:01:16

Is Curing Stage IV Gastric Cancer Possible? w/ Dr. Brian Badgwell
17:31

Total Neoadjuvant Therapy in Rectal Cancer in the Community Setting
1:36:57

A Look at the Invisible Symptoms of MS - August 9th, 2014 - with Brian Steingo, MD
20:23

How Long Do Chemotherapy Side Effects Last? All You Need to Know
56:48

Immunotherapy for Gastroesophageal Cancer
58:07

USRPT Presentation ASCA 2016 // Peter Andrew
51:14

Health Matters 2024: Brain Power - How Science Is Revolutionizing Cognitive Health
09:56

Statins Explained in 10 Minutes (by a cardiologist)
19:45

Anti Estrogen Therapy Symptom Management

Similar videos

14:58

2021 West Oncology | Hematological Malignancies | Updates in Myelodysplastic Syndromes
02:01

Treatment Advances for Aging AML Patients
01:26

Updates in the treatment landscape of p53-mutated AML/MDS
55:01

Oncology Nurse Perspectives, Principles, and Practice in an Era of Innovative AML Therapies
03:37

The future of AML treatment
05:11

The frontline treatment strategy for newly diagnosed AML
01:05

Updates on KO-539 as a treatment for AML
1:39:23

Treating MDS: What to Expect from Treatment
01:32

MDS, inflammation and AML
01:09

Advice for MDS patients in the COVID-19 era
01:21

What is the future of AML treatment? #AML
01:54

New developments in AML treatment
02:00

Has AML Monitoring and Treatment Changed During COVID 19
01:39

IPSS-R vs IPSS-M for MDS
09:24

How could new treatment combinations improve outcomes in TP53 mutant AML?
01:37

Dr. Saunthararajah on Mechanisms of Resistance to 5-Azacytidine/Decitabine in MDS-AML
1:00:08

GYN Gynecologic and ovarian cancer BCOP 2021